HOSPITAL PRIVACY CURTAIN SUPPLY BUSINESS PLAN

I. Executive Summary

Company Description

ClearGuard Manufacturing—named to convey visible protection and ease of use—launches in 2026 as a U.S.-based manufacturer serving the healthcare textile sector. We make advanced privacy curtains and integrated hardware, combining antimicrobial and flame-retardant textiles with precision mechanical tracks and mounts. Our direct-from-manufacturer model removes middlemen, lowers lead times, and tightens quality control. Production uses state-of-the-art cutting and sewing systems to enforce consistent stitch strength, seam sealing, and fabric treatments that meet healthcare infection-control and fire-safety standards. One-liner: High-quality curtains, built and shipped directly from our factory to clinical sites.

We sell nationwide to hospitals, surgical centers, and long-term care facilities, targeting procurement managers and infection-control officers who need durable, code-compliant privacy solutions. Main activities include made-to-order manufacturing, inventory-managed bulk programs, warranty-backed installations, and responsive replacement service. Leadership combines operations, medical sales, and infection-control expertise to shorten specification cycles and simplify installation. Short-term goal: win 12 pilot hospital accounts and reach positive gross margin within 12 months. Long-term goal: supply 10% of U.S. acute-care curtain replacements by year five while expanding modular hardware patents. One-liner: Scalable manufacturing and clinical expertise aimed at predictable, compliant curtain supply.

Problem

Healthcare facilities face a persistent infection-control and operational gap: traditional privacy curtains act as reservoirs for pathogens and contribute to hospital-acquired infections (HAIs). They increase infection risk, require frequent laundering and replacement, consume staff time, and can compromise patient privacy and dignity.

Current curtain solutions are hard to clean, slow to replace, often arrive worn or malfunctioning, and lack standardized, easy-to-install antimicrobial options that meet protocols—raising downtime, labor costs, and exposure risk for staff and patients.

We are a United States–based manufacturer launching in 2026 that produces antimicrobial, flame-retardant privacy curtains and hardware through a direct-from-manufacturer model; our facility uses advanced cutting and sewing equipment, and our leadership combines operations, medical sales, and infection-control expertise.

One line: Hospitals and long-term care facilities need a standardized, low-downtime privacy-curtain solution that reduces HAIs, cuts operating cost, and protects patient privacy.

Solution

Healthcare facilities face curtains that trap pathogens, take hours to replace, and cause room downtime and labor costs. We supply a domestic line of privacy curtains engineered for clinical settings that meet flame-retardant standards, resist microbial growth, and withstand industrial cleaning to improve hygiene and turnover efficiency.

Standard Antimicrobial Curtain: fabric treated to inhibit microbial growth and meet flame-retardant requirements. Premium Quick Change System: advanced antimicrobial fabric plus proprietary quick-change hardware for rapid installation and removal. Durability & Maintenance: designed to withstand industrial cleaning protocols and frequent handling, delivered direct from manufacturer to ensure quality and steady supply.

Mission Statement

Our mission is to enhance patient safety and operational efficiency in healthcare facilities by manufacturing innovative, high-performance privacy solutions that integrate advanced antimicrobial textile technology. We commit to reducing hospital-acquired infections, empowering staff with easy-to-use systems that lower labor burden, and delivering consistent quality and value through domestic manufacturing and direct distribution. We aim to set the gold standard for medical privacy systems across the United States.

Key Success Factors

Success rests on our proprietary technology, significant labor savings, U.S. manufacturing, GPO relationships, high-margin products, and experienced management.

• Proprietary technology and quick-change system that reduces facility labor time.
• U.S.-based manufacturing enabling rapid response and healthcare regulatory compliance.
• GPO relationships that provide a scalable path to national market penetration.
• High-margin specialized product lines supporting robust EBITDA and rapid ROI.
• Experienced management delivering excellence in production and clinical sales.

Financial Summary

Fast path to profitability: first-year revenue of $6,905,000 with breakeven in Jan-26 and one-month payback.

Financial needs: minimum cash on hand of $1,154,000 (Jan-26) and planned capex of $835,000 (total), for combined liquidity need of $1,989,000; anticipated return metrics are IRR 293.39% and ROE 68.99%.

Outlook: strong margin profile and rapid payback support a high-return, low-duration investment thesis.

Funding Requirements

We require a one-time capital injection of USD 2,054,000 to launch in January 2026; projected first-year revenue is USD 6,905,000, initial EBITDA USD 4,485,000, five-year revenue USD 31,090,000, five-year EBITDA USD 23,136,000, IRR 293.39%, breakeven in month 1, and total payback in one month.